权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Development of a clinical application of Cordyceps sinensis as an antimetastatic agent utilizing the properties of its active ingredient

利用冬虫夏草活性成分的特性开发其作为抗转移剂的临床应用

基本信息

批准号：
18590127
负责人：
NAKAMURA Kazuki
金额：
$ 1.79万
依托单位：
Mukogawa Women's University
依托单位国家：
日本
项目类别：
Grant-in-Aid for Scientific Research (C)
财政年份：
2006
资助国家：
日本
起止时间：
2006 至 2007
项目状态：
已结题

项目摘要

We demonstrated that cordycepin (3'-deoxyadenosine) is an active ingredient of water extracts of the fruiting bodies of cultured Cordyceps sinensis (WECS). In the first year of this project, I investigated the adjuvant effect of 2'-deoxycoformycin (DCF), an adenosine deaminase inhibitor, on the antitumor actions of WECS and cordycepin using mouse B16-BL6 melanoma and Lewis lung carcinoma cells in vitro. As a result, DCF at 5 μM reinforced the antitumor effect of WECS and cordycepin, three and three hundred-fold, respectively. DCF alone at 5 μM was wholly ineffective on the growth curves of both cell lines. In the second year of this project, we evaluated the antimetastatic effect of WECS on a spontaneous metastatic mouse model, prepared by inoculation with B16-BL6 cells into the footpad of the right hind leg. Two weeks after inoculation, the primary tumor was completely resected. DCF (0.05 mg/kg) alone or DCF plus WECS (10 mg/kg) administered intraperitoneally for one week after tumor inoculation and for one week after primary tumor resection did not prolong the survival of model mice, while WECS (10 mg/kg) alone administered intraperitoneally for the same, duration significantly prolonged mouse survival compared with that of control mice, as shown on Kaplan-Meier analysis. Survival time of control mice was less than 53 days in all cases, while three of six mice that were administered WECS (10 mg/kg) survived over 110 days. None of the mice administered WECS (10 mg/kg) showed adverse systemic effects. WECS at 3 mg/kg did not show any antimetastatic action, while WECS at 100 mg/kg significantly reduced the body weights of mice as an adverse effect. In conclusion, after removing its inactive components, WECS should be a candidate for clinical use as an antimetastatic agent.

证明虫草素(3‘-脱氧腺苷)是人工培养冬虫夏草子实体水提物中的有效成分。在本项目的第一年，我在体外用小鼠B16-BL6黑色素瘤和Lewis肺癌细胞研究了腺苷脱氨酶抑制剂2‘-脱氧辅酶(DCF)对WECS和虫草素抗肿瘤作用的辅助作用。结果表明，5μM的DCF3次作用可使西洋参多糖和虫草素的抗肿瘤作用分别增强3倍和300倍。5μM的DCF单独作用对两种细胞的生长曲线均无明显影响。在这个项目的第二年，我们评估了WECS在小鼠自发转移模型上的抗转移作用，该模型是通过将B16-BL6细胞接种到右后腿足垫来制备的。接种2周后，原发灶完全切除。Kaplan-Meier分析显示，DCF(0.05 mg/kg)单独或DCF+WECS(10 mg/kg)在肿瘤接种后1周和初次肿瘤切除后1周均不能延长模型小鼠的存活时间，而WECS(10 mg/kg)单独腹腔注射的时间与对照组相比显著延长。对照组小鼠的存活时间在所有病例中均小于53天，而给予WECS(10 mg/kg)的6只小鼠中有3只存活超过110天。给予WECS(10 mg/kg)的小鼠均未出现不良全身反应。3 mg/kg的WECS未显示任何抗肿瘤转移作用，而100 mg/kg的WECS则明显减轻小鼠的体重。综上所述，去除非活性成分后，WECS应可作为抗肿瘤药物的临床候选药物。

项目成果

期刊论文数量（0）

专著数量（0）

科研奖励数量（0）

会议论文数量（0）

专利数量（0）

Cordycepin(3'-deoxyadenosine)reduces the growth of B 16-BL6 mouse melanomacells through the adenosine A_3 receptor followed by Wnt signaling pathway

虫草素（3-脱氧腺苷）通过腺苷 A_3 受体和 Wnt 信号通路减少 B 16-BL6 小鼠黑色素瘤细胞的生长

DOI：
发表时间：
2007
期刊：
影响因子：
0
作者：
Kazuki Nakamura;et. al.;Kazuki Nakamura
通讯作者：
Kazuki Nakamura

4種のマウスメラノーマ細胞における転移先臓器指向性の違いについて

四种小鼠黑色素瘤细胞转移器官趋向性的差异

DOI：
发表时间：
2008
期刊：
影响因子：
0
作者：
Namie Nejime;Noriko Yoshikawa;Noriko Yoshikawa;Noriko Yoshikawa;久保えり香;吉川紀子;久保えり香;Noriko Yoshikawa;Noriko Yoshikawa;吉川紀子;吉川紀子;禰占奈美江;久保えり香
通讯作者：
久保えり香

Potential for liver metastasis did not correlate with that for lung metastasis in a study using four different mouse melanoma cell lines

在使用四种不同小鼠黑色素瘤细胞系的研究中，肝转移的可能性与肺转移的可能性不相关